Affluent Medical (XPAR:AFME) Debt-to-Equity : 0.53 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical Debt-to-Equity?

Affluent Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €1.78 Mil. Affluent Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €15.06 Mil. Affluent Medical's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €31.53 Mil. Affluent Medical's debt to equity for the quarter that ended in Dec. 2023 was 0.53.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Affluent Medical's Debt-to-Equity or its related term are showing as below:

XPAR:AFME' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.52 Max: 0.76
Current: 0.53

During the past 8 years, the highest Debt-to-Equity Ratio of Affluent Medical was 0.76. The lowest was 0.05. And the median was 0.52.

XPAR:AFME's Debt-to-Equity is ranked worse than
72.86% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs XPAR:AFME: 0.53

Affluent Medical Debt-to-Equity Historical Data

The historical data trend for Affluent Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical Debt-to-Equity Chart

Affluent Medical Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.76

0.59

0.45

0.52

0.53

Affluent Medical Semi-Annual Data
	Dec16	Dec17	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial						0.45	0.53	0.52	0.45	0.53

Competitive Comparison of Affluent Medical's Debt-to-Equity

For the Medical Devices subindustry, Affluent Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affluent Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Affluent Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Affluent Medical's Debt-to-Equity falls into.

Affluent Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Affluent Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.778	+	15.057)	/	31.525
	=	0.53

Affluent Medical's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.778	+	15.057)	/	31.525
	=	0.53

Affluent Medical (XPAR:AFME) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Affluent Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Affluent Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Affluent Medical (XPAR:AFME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (XPAR:AFME) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0JZ:Germany

Address

320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100

Website

https://www.affluentmedical.com

Affluent Medical is a medical device company. The company developing innovative, next-generation best-in-class minimally invasive implants to restore key physiological functions in the treatment of heart and vascular diseases.

Affluent Medical (XPAR:AFME) Headlines

No Headlines